Rd. Kirkby et al., FACTORS DETERMINING PROCONVULSANT AND ANTICONVULSANT EFFECTS OF INHIBITORS OF NITRIC-OXIDE SYNTHASE IN RODENTS, Epilepsy research, 24(2), 1996, pp. 91-100
Although a majority of studies suggest that inhibitors of nitric oxide
synthase (NOS) are proconvulsant, a substantial minority indicate the
opposite (i.e. that inhibitors of NOS are anticonvulsant). As a conse
quence, the role of endogenous nitric oxide (NO) in the expression of
seizures is unclear. In the present series of experiments, we therefor
e assessed factors governing pro- and anticonvulsant effects of inhibi
tors of NOS. In mice receiving systemic injections of kainate or picro
toxin, we confirmed the hypothesis that the effects of inhibitors of N
OS vary with the model of seizure: Whereas 7-nitroindazole (7-NI) redu
ced the latency and increased the severity of kainate-induced convulsi
ons (Expt. 1), both 7-NI and N-omega-nitro-L-arginine methyl ester (L-
NAME) slightly delayed clonus following the systemic administration of
picrotoxin at doses greater than or equal to 3.5 mg/kg but not at dos
es less than or equal to 3.0 mg/kg (Expts. 2-5). Paradoxically, L-NAME
but not 7-NI significantly reduced the CD50 of picrotoxin, which was
approximately 2 mg/kg in control mice (Expt. 4), revealing inhibitor-s
pecific interactions with the dose of the convulsant. Finally, we dete
rmined in rats that the effects of L-NAME on kainate-induced seizures
vary as a function of genetic factors: L-NAME significantly potentiate
d kainate-induced convulsions in Sprague-Dawley rats but not in Wistar
rats (Expt. 6).